The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions
Open accessAbstract
Inflammatory bowel disease (IBD) is a complex and multifaceted disorder of the gastrointestinal tract that is increasing in incidence worldwide and associated with significant morbidity. The rapid accumulation of large datasets from electronic health records, high-definition multi-omics (including genomics, proteomics, transcriptomics, and metagenomics), and imaging modalities (endoscopy and endomicroscopy) have provided powerful tools to unravel novel mechanistic insights and help address unmet clinical needs in IBD. Although the application of artificial intelligence (AI) methods has facilitated the analysis, integration, and interpretation of large datasets in IBD, significant heterogeneity in AI methods, datasets, and clinical outcomes and the need for unbiased prospective validations studies are current barriers to incorporation of AI into clinical practice. The purpose of this review is to summarize the most recent advances in the application of AI and machine learning technologies in the diagnosis and risk prediction, assessment of disease severity, and prediction of clinical outcomes in patients with IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, there is significant heterogeneity in terms of the datasets AI algorithms are trained with within algorithm types themselves13,14.”
From Bias in AI-based models for medical applications: challenges and mitigation strategies (2023) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Daperno, M., D’Haens, G., Assche, G. V., Baert, F., Bulois, P., Maunoury, V., Sostegni, R., Rocca, R., Pera, A., Gevers, A., et al. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01878-4 · Cited by 1,779
Lewis, J. D., Chuai, S., Nessel, L. A., Lichtenstein, G. R., Aberra, F. N., & Ellenberg, J. H. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20520 · Cited by 965
Environmental triggers in IBD: a review of progress and evidence
Ananthakrishnan, A. N., Bernstein, C. N., Iliopoulos, D., Macpherson, A., Neurath, M. F., Ali, R. A. R., Vavricka, S. R., & Fiocchi, C. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.136 · Cited by 948
Wang, P., Berzin, T. M., Glissen Brown, J. R., Bharadwaj, S., Becq, A., Xiao, X., Liu, P., Li, L., Song, Y., Zhang, D., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317500 · Cited by 865
Current and emerging therapeutic targets for IBD
Neurath, M. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.208 · Cited by 717
Artificial intelligence, machine learning and health systems
Panch, T., Szolovits, P., & Atun, R. A. (2018) · Journal of Global Health · doi:10.7189/jogh.08.020303 · Cited by 679
Gillen, C. D., Walmsley, R. S., Prior, P., Andrews, H. A., & Allan, R. N. (1994) · Gut · doi:10.1136/gut.35.11.1590 · Cited by 515
Wang, W., & Siau, K. (2019) · Journal of Database Management · doi:10.4018/jdm.2019010104 · Cited by 452
The IBD interactome: an integrated view of aetiology, pathogenesis and therapy
de Souza, H. S. P., Fiocchi, C., & Iliopoulos, D. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.110 · Cited by 447
Cited by
Sorted by citations
Bias in AI-based models for medical applications: challenges and mitigation strategies
Mittermaier, M., Raza, M. M., & Kvedar, J. C. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00858-z · Cited by 372
Bedrikovetski, S., Dudi-Venkata, N. N., Kroon, H. M., Seow, W., Vather, R., Carneiro, G., Moore, J. W., & Sammour, T. (2021) · BMC Cancer · doi:10.1186/s12885-021-08773-w · Cited by 164
Canine chronic enteropathy—Current state-of-the-art and emerging concepts
Jergens, A. E., & Heilmann, R. M. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.923013 · Cited by 116
Cross-scale multi-instance learning for pathological image diagnosis
Deng, R., Cui, C., Remedios, L. W., Bao, S., Womick, R. M., Chiron, S., Li, J., Roland, J. T., Lau, K. S., Liu, Q., et al. (2024) · Medical Image Analysis · doi:10.1016/j.media.2024.103124 · Cited by 95
Artificial Intelligence in Genetics
Vilhekar, R. S., & Rawekar, A. (2024) · Cureus · doi:10.7759/cureus.52035 · Cited by 104
“…has made it simpler to analyze, combine, and interpret huge genetics datasets, the requirement for objective prospective validation studies, as well as the substantial heterogeneity in AI methods, datasets, and clinical outcomes, are currently preventing the use of AI in clinical practice [34].”
BackgroundAnti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives
Gubatan, J. M. B., Keyashian, K., Rubin, S. J. S., Wang, J., Buckman, C., & Sinha, S. R. (2021) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s293272 · Cited by 88
Self-citationMuzammil, M. A., Fariha, F., Patel, T., Sohail, R., Kumar, M., Khan, E. A., Khanam, B., Kumar, S., Khatri, M., Varrassi, G., et al. (2023) · Cureus · doi:10.7759/cureus.41120 · Cited by 76
“Large datasets from electronic health records, genomes, proteomics, and imaging modalities can be analyzed by AI applications like machine learning algorithms to get important insights into illness diagnosis, prognosis, and therapy response [67].”
BackgroundInflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases
Padoan, A., Musso, G., Contran, N., & Basso, D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45070350 · Cited by 74
“Interestingly, colonoscopy and endoscopic images were used for generating AI model, with or without the addition of biochemical and molecular data and gene expression profiles [159], and very relevant results on sensitivity and specificity were found.”
BackgroundMethodInfluentialInflammatory bowel diseases: pathological mechanisms and therapeutic perspectives
Yang, X., Guo, H., & Zou, M. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00395-z · Cited by 85
“While systems biology and machine learning have introduced novel avenues for multi-omic integration, methodological heterogeneity and variable clinical endpoints continue to impede their translational application [582].”
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review
Sedaño, R., Solitano, V., Vuyyuru, S. K., Yuan, Y., Hanžel, J., Ma, C., Nardone, O. M., & Jairath, V. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251321915 · Cited by 59
Kraszewski, S., Szczurek, W., Szymczak, J. E., Reguła, M., & Neubauer, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204745 · Cited by 47
Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials
Ahmad, H. A., East, J. E., Panaccione, R., Travis, S. P. L., Canavan, J. B., Usiskin, K., & Byrne, M. F. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad029 · Cited by 47
Pinton, P. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2300670 · Cited by 42
“Most studies evaluating AI for the diagnosis of IBD are based on either ML or convolutional neural networks to analyze genetic/genomic datasets, imaging and endoscopy datasets, and protein expression/proteomics datasets [3].”
BackgroundInfluentialCè, M., D’Amico, N. C., Danesini, G. M., Foschini, C., Oliva, G., Martinenghi, C. M. A., & Cellina, M. I. (2023) · BioMedInformatics · doi:10.3390/biomedinformatics3010002 · Cited by 41
Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers
Meštrović, A., Perković, N., Božić, D., Kumrić, M., Vilović, M., & Božić, J. (2024) · Biomedicines · doi:10.3390/biomedicines12071520 · Cited by 36
“These studies should involve large, diverse patient cohorts to validate the predictive accuracy and clinical utility of AI models [187,188].”
BackgroundGomollón, F., Gisbert, J. P., Guerra, I., Plaza, R., Pajares, R., Almazán, L. M., Martín, M. C. L., Antonaya, M. D., Mendoza, M. I. V., Aparicio, J., et al. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002317 · Cited by 35
Highlighting the Undetectable — Fluorescence Molecular Imaging in Gastrointestinal Endoscopy
Stibbe, J. A., Hoogland, P., Achterberg, F. B., Holman, D., Sojwal, R. S., Burggraaf, J., Vahrmeijer, A. L., Nagengast, W. B., & Rogalla, S. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-022-01741-1 · Cited by 34
New AI model for neoplasia detection and characterisation in inflammatory bowel disease
Abdelrahim, M., Siggens, K., Iwadate, Y., Maeda, N., Htet, H. M. T., & Bhandari, P. (2024) · Gut · doi:10.1136/gutjnl-2023-330718 · Cited by 35
“13 However, despite neoplasia detection being the primary aim of endoscopic surveillance in IBD, data on the application of this technology in neoplasia detection during endoscopic surveillance in an IBD setting remain very limited.”
BackgroundRole of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review
Majidova, K., Handfield, J., Kafi, K., Martin, R., & Kubinski, R. (2021) · Genes · doi:10.3390/genes12101465 · Cited by 34
Chen, L., Zhang, C., Niu, R., Xiong, S., He, J., Wang, Y., Zhang, P., Su, F., Liu, Z., Zhou, L., et al. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12720 · Cited by 37
“Promisingly, incorporating advanced technologies such as spatial transcriptomics, single‐ cell sequencing, systems biology, and artificial intelligence holds substantial potential for the in‐depth exploration of predictive biomarkers [91, 92].”
Balderramo, D. C. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i47.6743 · Cited by 33
Kiyokawa, H., Abe, M., Matsui, T., Kurashige, M., Ohshima, K., Tahara, S., Nojima, S., Ogino, T., Sekido, Y., Mizushima, T., et al. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2022.03.006 · Cited by 32
Stanković, B., Kotur, N., Nikčević, G., Gašić, V., Zukić, B., & Pavlović, S. (2021) · Genes · doi:10.3390/genes12091438 · Cited by 31
“One of the key challenges in this process is to effectively utilize information obtained in omics studies with patients’ data stored in electronic medical records (biochemistry tests, various imaging data, symptoms at diagnosis and lifestyle specifics) [38,91].”
BackgroundKang, S., Kim, H., Kim, S., Kim, J., Park, S., Lee, C.-W., Kim, K. O., Seo, G. S., Kim, M. S., Cha, J. M., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11071665 · Cited by 29
Zhang, L., Mao, R., Lau, C. T., Chung, W. C., Chan, J. C. P., Liang, F., Zhao, C., Zhang, X., & Bian, Z. (2022) · Scientific Reports · doi:10.1038/s41598-022-14048-6 · Cited by 27
He, J., Wang, S.-X., & Liu, P. (2024) · British Journal of Radiology · doi:10.1093/bjr/tqae098 · Cited by 25
Computational models in inflammatory bowel disease
Pinton, P. (2022) · Clinical and Translational Science · doi:10.1111/cts.13228 · Cited by 24
A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances
Abdulla, M., & Mohammed, N. (2022) · Biologics · doi:10.2147/btt.s380027 · Cited by 23
“In order to treat the massive data obtained, new algorithms and COVID –IBD data analysis methods should be elaborated by IA, ML and DL methods.(118)”
MethodLewis, J. R., Pathan, S., Kumar, P., & Dias, C. C. (2024) · IEEE Access · doi:10.1109/access.2024.3483432 · Cited by 21
Systematic review of artificial intelligence‐based image diagnosis for inflammatory bowel disease
Kawamoto, A., Takenaka, K., Okamoto, R., Watanabe, M., & Ohtsuka, K. (2022) · Digestive Endoscopy · doi:10.1111/den.14334 · Cited by 19
Vermeer, E., Jagt, J. Z., Lap, E. M., Struys, E. A., Budding, A. E., Verhoeven‐Duif, N. M., Bosma, M., Limbergen, J. V., Koot, B. G. P., de Jonge, R., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2517828 · Cited by 18
Cai, W., Xu, J., Chen, Y., Wu, X. H., Zeng, Y., & Yu, F. (2023) · Inflammation · doi:10.1007/s10753-023-01827-0 · Cited by 17
“A variety of applications of ML in IBD is reviewed elsewhere [33].”
BackgroundMethodLu, J., Wang, Z., Maimaiti, M., Hui, W., Abudourexiti, A., & Gao, F. (2021) · Human Cell · doi:10.1007/s13577-021-00641-w · Cited by 18
“Machine learning has been evaluated for clinical applications in patients with inflammatory bowel disease [14].”
Deo, D. D., Buono, A. D., Gabbiadini, R., Nardone, O. M., Ferreiro‐Iglesias, R., Privitera, G., Bonifacio, C., Acosta, M. B.-D., Bezzio, C., & Armuzzi, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1637159 · Cited by 22
Next-Generation Sequencing for the Detection of Microbial Agents in Avian Clinical Samples
Afonso, C. L., & Afonso, A. M. (2023) · Veterinary Sciences · doi:10.3390/vetsci10120690 · Cited by 17
Artificial intelligence and inflammatory bowel disease: practicalities and future prospects
Brooks-Warburton, J., Ashton, J. J., Dhar, A., Tham, T., Allen, P. B., Hoque, S., Lovat, L. B., & Sebastian, S. (2021) · Frontline Gastroenterology · doi:10.1136/flgastro-2021-102003 · Cited by 16
“Most of the existing literature on the use of AI in diagnosing IBD relates to developing risk prediction models using either ML or CNNs to analyse endoscopic and imaging datasets (8).”
Yang, L., Perry, E., Shan, L. L., Wilding, H., Connell, W., Thompson, A. J. V., Taylor, A. C. F., Desmond, P. V., & Holt, B. A. (2022) · Endoscopy International Open · doi:10.1055/a-1846-0642 · Cited by 16
Røyset, E. S., Pettersen, H. S., Xu, W., Larbi, A., Sandvik, A. K., Steigen, S. E., Catalán‐Serra, I., & Bakke, I. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.301 · Cited by 15
Zhong, W., Gong, J., Su, Q., Farag, M. A., Simal‐Gándara, J., Wang, H., & Cao, H. (2023) · Phytochemistry Reviews · doi:10.1007/s11101-023-09866-z · Cited by 15
“Additionally, these technologies can assist researchers in conducting genomic and metabolomic studies to identify the molecular mechanisms of polyphenols and evaluate their effectiveness in different individuals (Gubatan et al. 2021).”
Aljohani, A. A., Alharbe, N., Mamlook, R. E. A., & Khayyat, M. M. (2024) · Journal of King Saud University - Computer and Information Sciences · doi:10.1016/j.jksuci.2024.101961 · Cited by 15
Li, X., Yan, L., Wang, X., Ouyang, C., Wang, C., Chao, J., Zhang, J., & Lian, G. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1043412 · Cited by 13
Qiu, Y., Hu, S., Chao, K., Huang, L.-J., Huang, Z., Mao, R., Su, F., Zhang, C., Lin, X., Cao, Q., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae176 · Cited by 18
Akbarian, P., Asadi, F., & Sabahi, A. (2024) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2024.394 · Cited by 16
Boodaghidizaji, M., Cantu-Jungles, T. M., Chen, T., Zhang, B., Yao, T., LANDAY, A. L., Keshavarzian, A., Hamaker, B. R., & Ardekani, A. M. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04072-7 · Cited by 16
“Both CNN and ANN have been applied to different classification problems involving gut microbiota, such as obesity [28], inflammatory bowel disease [29], and Parkinson’s disease [30] detection.”
Cardoso, P., Mascarenhas, M., Afonso, J. P. L., Ribeiro, T., Mendes, F., Martins, M., Andrade, P., Cardoso, H., Mascarenhas, M., Ferreira, J. P. S., et al. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241251569 · Cited by 12
Yu, S., Zhang, M., Ye, Z., Wang, Y., Wang, X., & Chen, Y. (2023) · Cell Regeneration · doi:10.1186/s13619-022-00143-6 · Cited by 11
“Machine learning has facilitated the diagnosis and risk prediction of IBD, but there was considerable variability in the performance of the different algorithms across the various cohorts (Gubatan et al. 2021).”
BackgroundKhachatryan, L., Xiang, Y., Ivanov, A. B., Glaab, E., Graham, G. T., Granata, I., Giordano, M., Maddalena, L., Piccirillo, M., Manipur, I., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33050-0 · Cited by 12
“There were several studies dedicated to microbiome-based IBD diagnostics prior to the MEDIC challenge; however, most of these works are at risk of bias since the same sample cohort is used for algorithm training and testing, introducing potential limitations with generalizability 12 .”
Sinha, T., Zain, Z., Bokhari, S. F. H., Waheed, S., Reza, T., Eze-odurukwe, A., Patel, M., Almadhoun, M. K. I. K., Hussain, A., & Reyaz, I. (2024) · Cureus · doi:10.7759/cureus.55268 · Cited by 12
“Machine learning and artificial intelligence can be employed for analyzing large datasets to identify new risk factors, predict disease progression, and personalize treatment strategies [71,72].”
BackgroundDiscontinuation of therapy in inflammatory bowel disease: Current views
Meštrović, A., Kumrić, M., & Božić, J. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i10.1718 · Cited by 11
“In 2017, a consensus expert panel convened by the European Crohn’s and Colitis Organization gave practical instructions for exit strategies in the treatment of IBD[11].”
Deng, R., Cui, C., Remedios, L. W., Bao, S., Womick, R. M., Chiron, S., Li, J., Roland, J. T., Lau, K. S., Liu, Q., et al. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-18814-5_3 · Cited by 11
MICDnet: Multimodal information processing networks for Crohn’s disease diagnosis
Jia, Z., Wang, Y., Li, S., Yang, M., Liu, Z., & Zhang, H. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107790 · Cited by 12
Chen, D. J., Fulmer, C. G., Gordon, I. O., Syed, S., Stidham, R. W., Casteele, N. V., Qin, Y., Falloon, K., Cohen, B. L., Wyllie, R., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab169 · Cited by 10
Spatz, S. J., & Afonso, C. L. (2024) · Veterinary Sciences · doi:10.3390/vetsci11060239 · Cited by 12
“Gubatan et al. (2021) reviewed existing artificial intelligence applications in inflammatory bowel disease [126].”
BackgroundZhou, Q., Lan, L., Wang, W., & Xu, X. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-02853-8 · Cited by 10
Linking gene expression to clinical outcomes in pediatric Crohn’s disease using machine learning
Chen, K. A., Nishiyama, N. C., Ng, M. M. K., Shumway, A. J., Joisa, C. U., Schaner, M. R., Lian, G., Beasley, C., Zhu, L., Bantumilli, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52678-0 · Cited by 13
“Our study has important limitations.”
Rubin, D. T., Gottlieb, K. T., Colombel, J., Schott, J.-P., Erisson, L., Prucka, B., Phillips, S. A., Kwon, J., Ng, J., & McGill, J. M. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.06.003 · Cited by 9
Gene Identification in Inflammatory Bowel Disease via a Machine Learning Approach
Alfonso, G., & Castillo, R. (2023) · Medicina · doi:10.3390/medicina59071218 · Cited by 7
“This has been in part due to the large amount of data generated experimentally [41] and the need to come up with appropriate techniques to analyze such a large quantity of data.”
BackgroundSood, D., RIAZ, Z. M., Mikkilineni, J., Ravi, N. N., Chidipothu, V., Yerrapragada, G., Poonguzhali, E., Shariff, M. N., Natarajan, T. K., Janarthanan, J., et al. (2025) · Medical Sciences · doi:10.3390/medsci13040230 · Cited by 8
“No current system has been tested in real-world workflows or been shown to impact clinical endpoints [15,50,71,72].”
InfluentialBai, X., Guo, Y., Zhu, X.-M., & Dai, D. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002219 · Cited by 7
A review of disease risk prediction methods and applications in the omics era
Sun, C., Cheng, X., Xu, J., Chen, H., Tao, J., Dong, Y., Wei, S., Chen, R., Meng, X., Ma, Y., et al. (2024) · PROTEOMICS · doi:10.1002/pmic.202300359 · Cited by 7
Hassan, A., Abujabal, H. A. S., Ahmad, S., Malebary, S. J., & Alromema, N. A. (2024) · Diagnostics · doi:10.3390/diagnostics14111182 · Cited by 6
Gastrointestinal disorders in children with autism: Could artificial intelligence help?
Al‐Beltagi, M., Saeed, N. K., & Qaraghuli, S. (2022) · Artificial Intelligence in Gastroenterology · doi:10.35712/aig.v3.i1.1 · Cited by 6
Neklesova, M. V., Sogomonyan, K. S., Golovkin, I. A., Shirokiy, N. I., Vershinina, S. O., Tsvetikova, S. A., Korzhova, J. E., Zakharova, M. N., & Gnedovskaya, E. V. (2025) · Biomedicines · doi:10.3390/biomedicines13081806 · Cited by 6
“…significance of the microbiota in MS. Advances in machine learning (ML) have enabled the identification of disease-specific microbial signatures in conditions such as type 2 diabetes (T2D) [16], inflammatory bowel diseases (IBD) [17], colorectal cancer (CRC) [18], and neurological disorders [19].”
Jeong, J., Hong, S. T., Ullah, I., Kim, E. S., & Park, S. H. (2022) · Diagnostics · doi:10.3390/diagnostics12020288 · Cited by 5
“To the best of our knowledge, no study has classified CRC and IBD by using a machine learning-based method.”
MethodInfluentialGavrilescu, O., Popa, I. V., Dranga, M., Mihai, R., Prelipcean, C. C., & Mihai, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113609 · Cited by 5
Horvath, A.-S., & Pouliou, P. (2024) · CRC Press eBooks · doi:10.1201/9781003425724-46 · Cited by 7
Cold, K. M., Vamadevan, A., Heen, A., Vilmann, A. S., Rasmussen, M., Konge, L., & Svendsen, M. B. S. (2025) · Diagnostics · doi:10.3390/diagnostics15050591 · Cited by 5
Ricci, L., Toussaint, Y., Becker, J., Najjar, H., Renier, A., Choukour, M., Buisson, A., Devos, C., Epstein, J., Peyrin‐Biroulet, L., et al. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.09.005 · Cited by 7
Thick Data Analytics for Rating Ulcerative Colitis Severity Using Small Endoscopy Image Sample
Fiaidhi, J., Zezos, P., & Mohammed, S. (2021) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata52589.2021.9671327 · Cited by 5
“…learning has helped the analysis of large datasets in UC/CD conditions and in clustering the severity of these conditions reaching the level of human reviewer [3], significant heterogeneity exists in machine learning methods relevant to the available datasets with varying clinical outcomes [4].”
BackgroundArtificial intelligence in colorectal cancer screening in patients with inflammatory bowel disease
Marques, K. F., Marques, A. F., Lopes, M. A., Beraldo, R. F., Lima, T. B., & Sassaki, L. Y. (2022) · Artificial Intelligence in Gastrointestinal Endoscopy · doi:10.37126/aige.v3.i1.1 · Cited by 5
Liu, Z.-G., & Xie, S. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i42.112107 · Cited by 6
“Studies suggest that radiomics can provide objective measures of mucosal inflammation, potentially complementing or substituting for endoscopy in certain scenarios[23,24].”
Chai, E., Gu, X., Lu, Z., & Cui, T. (2026) · Expert Systems with Applications · doi:10.1016/j.eswa.2026.131298 · Cited by 4
Zeng, S., Dong, C., Liu, C., Zhen, J., Pu, Y., Hu, J., & Dong, W. (2025) · Digital Health · doi:10.1177/20552076251326217 · Cited by 4
Kumarasamy, G., Salim, N. H. M., Afandi, N. S. M., Habib, M. A. H., Amin, N. D. M., Ismail, M. N., & Musa, M. (2023) · Future Oncology · doi:10.2217/fon-2023-0704 · Cited by 4
Role of artificial intelligence in Crohn's disease intestinal strictures and fibrosis
Chen, Y. F., Liu, L., Lü, B., Yang, Y., Zheng, S. S., Huang, X., Xu, Y., & Fan, Y. H. (2024) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13308 · Cited by 4
“15 In addition to its utility in endoscopic techniques, AI has also been reported to have a high accuracy in evaluating the severity of IBD based on clinical data of the patients, such as biochemical parameters, with algorithms such as CNN and SVM. 16 Studies have employed ML algorithms to predict disease risk based o…”
InfluentialGuo, L., Fu, K., Wang, W., Zhou, L. Q., Chen, L., & Jiang, M. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-01878-9 · Cited by 3
“AI has been employed for assessing colonic polyps [24], adenomas [25], colorectal cancer [26], ulcerative colitis [27], and intestinal motility disorders in colorectal diseases [28].”
Palmieri, O., Cannarozzi, A. L., Latiano, A., Massimino, L., Bossa, F., Riva, M., Ungaro, F., Guerra, M., Brina, A. L. P. D., Carparelli, S., et al. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00758-5 · Cited by 3
“Among the applications of AI in IBD, the integration and analysis of multi-omics data have enabled a better understanding of disease pathogenesis and the identification of diagnostic and therapeutic biomarkers [30].”
Suarez, M., Martínez, R., González-Martínez, F., Torres, A. M., & Mateo, J. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i2.114834 · Cited by 4
Huynh, C. D. (2026) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2026.100386 · Cited by 4
Woźniak, S., Pawluś, A., Grzelak, J., Chobotow, S., Paulsen, F. P., Olchowy, C., & Zaleska–Dorobisz, U. (2022) · Anatomical Science International · doi:10.1007/s12565-022-00681-8 · Cited by 3
“It can also be used to assess the quality of bowel preparation before the examination (Gubatan et al. 2021; Yang and Bang 2019; Yoo et al. 2021).”
MethodManzari, Z. S., Ghaderi, M. S., Vossoughinia, H., Rafiei, H., & Mafi, M. H. (2024) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_200_24 · Cited by 3
Central resources of variant discovery and annotation and its role in precision medicine
Halim‐Fikri, H., Syed-Hassan, S.-N. R.-K., Juhari, W. K. W., Assyuhada, M. G. S. N., Hernaningsih, Y., Yusoff, N. M., Merican, A. F., & Zilfalil, B. A. (2022) · Asian Biomedicine · doi:10.2478/abm-2022-0032 · Cited by 3
“To illustrate, Gubatan et al. [81] explained the most recent advanced technologies of AI in disease diagnosis, risk prediction, and disease severity evaluation, as well as prediction of clinical decision-making in IBD patients.”
BackgroundPredictive approaches in inflammatory bowel disease
Pinton, P. (2021) · Clinical and Translational Science · doi:10.1111/cts.13179 · Cited by 3
Collecting and Analyzing IBD Clinical Data for Machine-Learning: Insights from an Italian Cohort
Marzullo, A., Savevski, V., Menini, M., Schilirò, A., Franchellucci, G., Dal Buono, A., Bezzio, C., Gabbiadini, R., Hassan, C., Repici, A., et al. (2025) · Data · doi:10.3390/data10070100 · Cited by 2
Biomarkers for Disease Activity in Inflammatory Bowel Disease
Devi, J., Samaan, S., Syal, G., & Deepak, P. (2025) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2025.08.003 · Cited by 2
Chougule, P. R., & Sinha, S. N. (2025) · NAM journal. · doi:10.1016/j.namjnl.2025.100051 · Cited by 2
“The application of AI and ML in IBD has expanded rapidly, providing powerful in silico tools to analyse and interpret complex datasets, ranging from genetic and molecular signatures to histological images, endoscopic data, and electronic health records (Gubatan et al., 2021).”
Self-citationDignass, A. U., Narula, N., Pratap, K., Danese, S., Dotan, I., Iacucci, M., Jairath, V., Loftus, E. V., Magro, F., Mantzaris, G. J., et al. (2026) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjag007 · Cited by 2
najih, N. E., & Moussa, P. A. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-47366-1_1 · Cited by 1
Artificial intelligence and colonoscopy − enhancements and improvements
Yoo, B. S., D’Souza, S. M., Houston, K. V., Patel, A., Lau, J., Elmahdi, A., Parekh, P. J., & Johnson, D. (2021) · Artificial Intelligence in Gastrointestinal Endoscopy · doi:10.37126/aige.v2.i4.157 · Cited by 2
Self-citationDeSantis, A., Buss, K., Coker, K., Pasternak, B. A., Chi, J., Patterson, J. S., Gu, H., Jurutka, P. W., & Sandrin, T. R. (2025) · Biomolecules · doi:10.3390/biom15050746 · Cited by 1
“Leveraging machine learning and AI may also enhance predictive modeling for PIBD diagnosis and biomarker discovery [84].”
Gottlieb, K. T., Battioui, C., Wang, Y., Brodskiy, P., Haft‐Javaherian, M., Colucci, D. R., Thomason, D., & Baxi, S. S. (2025) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2025-001959 · Cited by 1
“6 7 16–18 While these endeavours have proven worthy, with several AI models exhibiting high agreement with human readers, relying solely on these models for central reading poses its own set of limitations, including a lack of regulatory guidance, unclear acceptance criteria and insufficient…”
Priorities for advancing artificial intelligence in inflammatory bowel disease: a technology update
Silverman, A. L., Stidham, R. W., Parasa, S., Sharma, P., & Mahadevan, U. (2026) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2025.12.248 · Cited by 1
Almajdi, A., & Shehab, M. (2026) · Biomedicines · doi:10.3390/biomedicines14040798 · Cited by 1
“Collectively, AI serves as a critical tool for personalized IBD care, supporting treat-ment decisions that reflect each patient’s unique biological, clinical, and molecular profile [38].”
Jiang, X., Li, P., Chen, Z., Yao, H., Jia, H., Wang, T., & Tang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1841261 · Cited by 1
Artificial intelligence in gastrointestinal endoscopy: evolution to a new era
Ortíz, O., Esparrach, M. G. F., Daca-Álvarez, M., & Pellisé, M. (2022) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2022.8961/2022 · Cited by 1
Afonso, J. P. L., Martins, M., Ferreira, J. P. S., & Mascarenhas, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99647-1.00003-4 · Cited by 2
Karakasidis, E. (2025) · Health and Technology · doi:10.1007/s12553-025-00997-1 · Cited by 1
Utility of artificial intelligence in colonoscopy
Shah, N., Jyala, A., Patel, H., & Makker, J. S. (2021) · Artificial Intelligence in Gastrointestinal Endoscopy · doi:10.37126/aige.v2.i3.79
Utility of artificial intelligence in colonoscopy
Shah, N., Jyala, A., Patel, H., & Makker, J. S. (2021) · Artificial Intelligence in Gastrointestinal Endoscopy · doi:10.37126/aige.v2.i3.78
Deep Learning Framework for Cancer Diagnosis and Treatment
Bahadur, S., & Kumar, P. (2022) · doi:10.1002/9781119857983.ch8
Metadata
- Authors
- Gubatan, J., Levitte, S., Patel, A., Balabanis, T., Wei, M. T., & Sinha, S. R.
- Affiliations
- Stanford Medicine (US)
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2021-05-07
- Volume
- 27
- Issue
- 17
- Pages
- 1920-1935
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC8108036
- OpenAlex
- W3157079437
- Cited by
- 121
- References
- 94
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 21 · 2023: 21 · 2022: 20 · 2021: 16
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- inflammatory bowel disease, artificial intelligence, machine learning, diagnosis, risk prediction, disease severity assessment, clinical outcome prediction, multi-omics data, endoscopy, endomicroscopy, electronic health records, clinical validation
- MeSH terms
- Artificial Intelligence, Colitis, Humans, Prospective Studies, Inflammatory Bowel Diseases, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review